Gish Biomedical's profits rise 33% despite weak sales
This article was originally published in Clinica
Executive Summary
Improved gross profit margins helped boost Gish Biomedical's net income 33% to $1.7 million in the year to June. "Gross profit margin improvements were a function of changes in product sales mix, increased productivity and decreases in certain components of overhead," says CFO Jeanne Miller.